Literature DB >> 945490

Dapsone motor neuropathy--an axonal disease.

L Gutmann, J D Martin, W Welton.   

Abstract

Dapsone produces a potentially reversible toxic neuropathy, with its primary effect on the soma and axons of motor neurons as opposed to myelin. There is very little evidence to suggest involvement of sensory axons in most cases; if present, it would appear minimal. A "dying back" of motor axons is postulated to produce the clinical features of primarily distal weakness and wasting. Recovery appears to occur via axon regeneration and peripheral sprouting. The sporadic occurrence of this neuropathy may be due to slow acetylation of dapsone in some patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 945490     DOI: 10.1212/wnl.26.6.514

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Dapsone-induced optic atrophy and motor neuropathy.

Authors:  T K Daneshmend; M Homeida
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-25

2.  Dapsone-induced optic atrophy and motor neuropathy.

Authors:  M Homeida; A Babikr; T K Daneshmend
Journal:  Br Med J       Date:  1980-11-01

3.  Peripheral motor neuropathy caused by excessive intake of dapsone (Avlosulfon).

Authors:  I Rosén; R Sörnäs
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

Review 4.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

Review 5.  Acetylation as an indicator of risk.

Authors:  N P Lang
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.